Brad Lidge Injury: Washington Closer Expected To Return In One Month

Washington Nations closer Brad Lidge underwent surgery on Tuesday morning to repair a sports hernia, which reportedly went "very well." When he returns, though, is the next question. Nats manager Davey Johnson appears optimistic that such a date will be sooner rather than later, telling CSNWashington.com writer Mark Zuckerman that Lidge should be back in the bullpen in about one month.

Davey: Lidge expected back in 1 month following surgery today for sports hernia.

Lidge last appeared this season in an April 21 game against the Miami Marlins, where he gave up two runs and three walks over the span of one inning. On the season, he has struggled a bit more than usual, posting an ERA of 5.14.

For more updates on the status of Brad Lidge, keep it tuned to this StoryStream. For all the latest news and analysis on the Washington Nationals, make sure to visit Federal Baseball.

Trending Discussions

X
Log In Sign Up

forgot?
Log In Sign Up

Forgot password?

We'll email you a reset link.

If you signed up using a 3rd party account like Facebook or Twitter, please login with it instead.

Forgot password?

Try another email?

Almost done,

By becoming a registered user, you are also agreeing to our Terms and confirming that you have read our Privacy Policy.

Join SB Nation DC

You must be a member of SB Nation DC to participate.

We have our own Community Guidelines at SB Nation DC. You should read them.

Join SB Nation DC

You must be a member of SB Nation DC to participate.

We have our own Community Guidelines at SB Nation DC. You should read them.

Spinner.vc97ec6e

Authenticating

Great!

Choose an available username to complete sign up.

In order to provide our users with a better overall experience, we ask for more information from Facebook when using it to login so that we can learn more about our audience and provide you with the best possible experience. We do not store specific user data and the sharing of it is not required to login with Facebook.